We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sandoz Wins European Approval for ESA Biosimilar
Sandoz Wins European Approval for ESA Biosimilar
September 7, 2007
The European Commission has approved Sandoz’s biosimilar epoetin alfa product, the first such product approved in Europe, the company announced.